Summary & Overview
CPT 00534: Anesthesia for Transvenous Cardioverter–Defibrillator Insertion
CPT code 00534 covers anesthesia for transvenous cardioverter–defibrillator insertion, a procedure essential for patients requiring advanced cardiac rhythm management. This code is nationally recognized and plays a significant role in the care of individuals with complex cardiac conditions, such as heart failure, valve disorders, and coronary artery disease. The procedure is typically performed in an inpatient hospital setting, reflecting its clinical complexity and the need for comprehensive monitoring.
Major payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. The publication provides a detailed overview of payer coverage, clinical context, and relevant policy updates for this anesthesia service. Readers will gain insights into coding benchmarks, common modifiers, and associated clinical diagnoses, as well as related procedural codes that often accompany this service. The summary also highlights the importance of accurate coding and documentation for anesthesia services in cardiac device insertion, ensuring compliance and appropriate reimbursement across national payer networks.
This article is intended for healthcare professionals, billing specialists, and policy analysts seeking a concise yet comprehensive understanding of CPT code 00534 and its place in the broader landscape of cardiac anesthesia services.
CPT Code Overview
CPT code 00534 is designated for anesthesia services provided during the transvenous insertion of a cardioverter–defibrillator. This procedure is classified under anesthesia for intrathoracic procedures, reflecting its complexity and the need for specialized anesthetic management. The typical site of service for this code is the inpatient hospital setting, specifically at Place of Service 21. These anesthesia services are critical for ensuring patient safety and comfort during the insertion of advanced cardiac devices.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult admitted to an inpatient hospital for the insertion of a transvenous cardioverter–defibrillator. The patient may have underlying cardiac conditions such as atherosclerotic heart disease, valvular insufficiency, or heart failure. The procedure is performed in a controlled hospital setting, with an anesthesiology physician or cardiac anesthesiology physician providing anesthesia care. The workflow includes preoperative assessment, administration of anesthesia, monitoring during the procedure, and postoperative recovery. The anesthesia service is specifically for intrathoracic procedures related to the placement of the cardioverter–defibrillator.
Coding Specifications
| Modifier Code | Description | Usage |
|---|---|---|
QS | Monitored anesthesia care service | Indicates that monitored anesthesia care was provided during the procedure. |
P1 | A normal healthy patient | Used to denote the physical status of the patient as normal and healthy. |
- Provider Taxonomies:
207L00000X- Anesthesiology Physician: Specialist in anesthesia care.207LA0401X- Cardiac Anesthesiology Physician: Specialist in anesthesia for cardiac procedures.207RC0000X- Cardiovascular Disease Physician: Specialist in cardiovascular disease management.
Related Diagnoses
-
I25.10- Atherosclerotic heart disease of native coronary artery without angina pectoris- Relevant for patients undergoing cardioverter–defibrillator insertion due to underlying coronary artery disease.
-
I34.0- Nonrheumatic mitral (valve) insufficiency- Indicates mitral valve dysfunction, which may contribute to arrhythmias or heart failure necessitating device placement.
-
I35.0- Nonrheumatic aortic (valve) stenosis- Aortic valve disease can lead to cardiac complications requiring defibrillator insertion.
-
I50.9- Heart failure, unspecified- Heart failure is a common indication for cardioverter–defibrillator placement to prevent sudden cardiac death.
-
Q21.1- Atrial septal defect- Congenital heart defect that may predispose patients to arrhythmias, making them candidates for device therapy.
Related CPT Codes
-
33405- Replacement, aortic valve; with cardiopulmonary bypass- This code is used for surgical replacement of the aortic valve, often performed in patients with aortic stenosis or insufficiency. It may require anesthesia services similar to those described by
00534.
- This code is used for surgical replacement of the aortic valve, often performed in patients with aortic stenosis or insufficiency. It may require anesthesia services similar to those described by
-
33533- Coronary artery bypass, using arterial graft(s); single arterial graft- Represents coronary artery bypass surgery, which may be performed in patients with atherosclerotic heart disease. Anesthesia for this procedure is related to
00534in terms of intrathoracic anesthesia care.
- Represents coronary artery bypass surgery, which may be performed in patients with atherosclerotic heart disease. Anesthesia for this procedure is related to
-
33208- Insertion of new or replacement of permanent pacemaker with transvenous electrode(s); atrial and ventricular- This code is for pacemaker insertion, a procedure similar to cardioverter–defibrillator placement. Anesthesia services for both procedures are closely related.
-
92980- Transcatheter placement of intracoronary stent(s), percutaneous, with coronary angioplasty when performed; single vessel- Used for percutaneous coronary interventions. While not always performed with anesthesia, it is related to the clinical workflow for patients with coronary artery disease.
National Reimbursement Benchmarks
National mean rates for CPT code 00534 show that Blue Cross Blue Shield and Cigna have the highest average reimbursement, at $398.43 and $403.49 respectively, while UnitedHealth Group is significantly lower at $65.66. The BUCA (average commercial) mean rate stands at $216.83, which is notably higher than typical Medicare rates, though Medicare-specific data is not available in the input.
Rate dispersion varies considerably across payers. UnitedHealth Group exhibits the tightest range, with a difference of $25.67 between the 75th and 25th percentiles, indicating less variability in payment amounts. In contrast, Cigna has the widest spread, with a $520.25 difference between its 75th and 25th percentiles, reflecting substantial variability in rates. Aetna and BUCA also show wide dispersions, while Blue Cross Blue Shield is moderately dispersed.
The table and chart below present a detailed breakdown of national benchmarks for each payer, including mean rates and percentile values.
State Benchmarks
State: AK1 / 50
Alaska Benchmarks
Alaska displays a wide range in reimbursement rates for CPT code 00534, with Blue Cross Blue Shield offering the highest mean rate at $485.32 and UnitedHealth Group the lowest at $75.12. The rate spread, calculated as the difference between the 75th and 25th percentiles, is most pronounced for Blue Cross Blue Shield ($252.83), while Aetna, Cigna, and UnitedHealth Group show minimal spreads, indicating consistent rates across providers. BUCA's spread ($271.98) also highlights significant variability.
Compared to national averages, Blue Cross Blue Shield's mean rate in Alaska is notably higher, while Aetna and BUCA are below their respective national means. The table and chart below present the full breakdown of payer-specific rates, illustrating the substantial variation in reimbursement across payers in Alaska.
Key Insights for Alaska
- Blue Cross Blue Shield is the highest paying payer for CPT 00534 in Alaska, with a mean rate of $485.32, while UnitedHealth Group is the lowest at $75.12.
- The rate spread is substantial, with BCBS's 75th percentile ($625.33) far exceeding Aetna, Cigna, and UnitedHealth Group, whose 75th percentiles cluster near $72–$93.
- Compared to national averages, Aetna and BUCA mean rates in Alaska are lower, while BCBS is notably higher than its national mean.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.